Professional Documents
Culture Documents
14 Biochemistry Lecture - Enzymes 3
14 Biochemistry Lecture - Enzymes 3
Medicine
Medical
Education-
Damietta
University
Level 1
Semester 1
Module 1B
Level 1
Semester 1
Module 1B
Introduction to Biochemistry
and
Basis of Genetics
Catalytic Proteins 4: Enzymes
Enzyme Regulation
• Contact: Medical Biochemistry Department.
• email: drosmanzaki@Hotmail.com
• Mobile: 01141512123
• Academic hours:
➢Sunday: 10:00-12:00 AM
➢Wednesday: 10:00-12:00 AM
Contents
• Enzyme Regulation:
• Induction.
• Repression.
• Allosteric regulation.
• Feedback inhibition.
• Pro-enzyme (zymogen).
• Covalent modification.
• Protein-protein interaction.
Learning outcomes
At the end of the lecture, the students should be
able to:
➢ Induction.
➢ Repression.
B) Altering the enzyme catalytic efficiency:
➢ Allosteric regulation.
➢ Feedback inhibition.
➢ Proenzyme (zymogen).
➢ Covalent modification.
Catalytic Protein
(Enzyme) Chemistry
ILO-1
ILO-2
1- Allosteric Regulation
Active site
E
Allosteric
site
❑ Allosteric means another site
❑ If binding of the effector to the enzyme increases it
activity, it is called positive effector or allosteric
activator e.g. ADP is allosteric activator for
phosphofructokinase enzyme.
❑ If binding of the effector to the enzyme causes a decrease in its
activity, it is called negative effector or allosteric inhibitor e.g.
➢ ATP and citrate are allosteric inhibitors for phosphofructokinase
enzyme.
➢ Glucose-6-phosphate is allosteric inhibitor for hexokinase
enzyme.
The allosteric site the
enzyme “on-off” switch
Active
site
E Allosteric
Substrate site empty Conformational E
fits into change Inhibitor
the active molecule
Substrate
site is present
cannot fit
The inhibitor into the
molecule is active site Inhibitor fits
absent into allosteric
site
Mechanism of allosteric regulation
Binding of the allosteric effector to the regulatory site
causes conformational changes in the catalytic site, which
becomes more fit for substrate binding in positive effector
(allosteric activator), and becomes unfit for substrate binding in
negative effector (allosteric inhibitor)
Allosteric regulation
• Conformational changes by regulatory molecules
– inhibitors
• keeps enzyme in inactive form
– activators
• keeps enzyme in active form
A→B→C→D→E→F→G
→
→
→
X
enzyme enzyme enzyme enzyme enzyme enzyme
1 2 3 4 5 6
(B) Binding to a site on the enzyme molecule far from the catalytic site
a) Activation by HCl
HCl
Pepsinogen Pepsin
Enterokinase
Trypsinogen Trypsin
Thrombokinase + Ca++
Prothrombin Thrombin
Biological importance of zymogens
(active form)
(inactive form)
Enzymes activated by phosphorylation:
❑ These are usually enzymes of degradative
(breakdown) reactions e.g.
1. Glycogen phosphorylase that breaks
down glycogen into glucose.
2. Lipase that hydrolyzes triglyceride into
glycerol and 3 fatty acids.
Enzymes inactivated by phosphorylation:
A) Zymogen
B) Ribozyme
C) Isozyme
D) Apoenzyme
(A) Alanine
(B) Lysine
(C) Phenylalanine
(D) Serine
Activity
• Discuss protein- protein interaction ( mechanism
,one example )
• Discuss proenzyme and its biomedical
importance
• Enumerate methods of covalent modification of
enzyme activity
• Discuss covalent modification by
phosphorylation (types, enzymes involved,
examples)
Catalytic Protein
(Enzyme) Chemistry
LO 3-
• What happened when Amal jogs? What does ATP use result in?
• When Amal jogs, the increased use of ATP for muscle contraction
results in an increase of AMP, which allosterically activates both the
allosteric enzyme phosphofructokinase1 and glycogen
phosphorylase. This is an example of feedback regulation by the
ATP/AMP ratio. Unfortunately, her low caloric consumption has not
allowed activation of the rate-limiting enzymes in her fuel storage
pathways, and she has very low glycogen stores. Consequently,
she has inadequate fuel stores to supply the increased energy
demands of exercise.
Feed back
References